Abstract
Sjögren’s syndrome patients manifest impaired serum DNase1 activity and increased serum levels of cell-free genomic DNA (cfDNA). Such circulating cfDNA may accumulate in tissues and may act as danger signal...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have